Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies.
Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies.
复制标题
DOI:
10.1021/acs.jmedchem.1c01081
复制
发表时间:
2021-12-23
影响因子:
7.3
通讯作者:
Jin C
中科院分区:
文献类型:
--
作者:
Guan D;Rahman MT;Gay EA;Vasukuttan V;Mathews KM;Decker AM;Williams AH;Zhan CG;Jin C
The central relaxin-3/RXFP3 system plays important roles in stress responses, feeding, and motivation for reward. However, exploration of its therapeutic applications has been hampered by the lack of small molecule ligands and the cross-activation of RXFP1 in the brain and RXFP4 in the periphery. Herein, we report the first structure–activity relationship studies of a series of novel nonpeptide amidinohydrazone-based agonists, which were characterized by RXFP3 functional and radioligand binding assays. Several potent and efficacious RXFP3 agonists (e.g., 10d) were identified with EC50 values <10 nM. These compounds also had high potency at RXFP4 but no agonist activity at RXFP1, demonstrating > 100-fold selectivity for RXFP3/4 over RXFP1. In vitro ADME and pharmacokinetic assessments revealed that the amidinohydrazone derivatives may have limited brain permeability. Collectively, our findings provide the basis for further optimization of lead compounds to develop a suitable agonist to probe RXFP3 functions in the brain.
登录
查看更多内容
影响因子:
14.8
作者:
Kozakov D;Hall DR;Xia B;Porter KA;Padhorny D;Yueh C;Beglov D;Vajda S
通讯作者:
Vajda S
DOI:
10.1124/jpet.104.073486
发表时间:
2005-01-01
影响因子:
3.5
作者:
Chen, JC;Kuei, C;Liu, CL
通讯作者:
Liu, CL
影响因子:
4.8
作者:
Liu, CL;Chen, JC;Lovenberg, TW
通讯作者:
Lovenberg, TW
影响因子:
4.7
作者:
Banerjee, Avantika;Shen, Pei-Juan;Gundlach, Andrew L.
通讯作者:
Gundlach, Andrew L.
影响因子:
7.3
作者:
Kocan, M.;Sarwar, M.;Summers, R. J.
通讯作者:
Summers, R. J.